The Center for Leadership Development (CLD; Indianapolis, IN) announced that it received a gift of $1 million from Indianapolis-based philanthropists Derica Rice and Robin Nelson-Rice.
CLD is dedicated to transforming the lives of African American youth in the Indianapolis community by preparing them for academic and career success. Specializing in developing the business and community leaders of the future, CLD’s impact reaches across industries, educational institutions, neighborhoods and generations.
While the Indiana Department of Education reports an average high school graduation rate of 76.9 percent for African American students statewide, 95 percent of CLD participants have successfully graduated from high school. Forty-four percent of CLD students come from single-parent households, 47 percent receive free or reduced lunches and 35 percent come from one of seven “hot spot” high-crime ZIP codes.
Derica Rice is a member of the CLD Board of Directors. He retired last year as executive vice president and chief financial officer at Eli Lilly and Company. Robin Nelson-Rice serves as a volunteer on a variety of community boards and institutions throughout Indianapolis, including the Indianapolis Museum of Art and The Women’s Fund.
Robin Nelson-Rice commented: “By connecting with schools, communities, businesses and higher education institutions, CLD inspires a level of academic and career achievement that is astonishing and unique. CLD had a profound impact on my life and I hope this gift can help impact the lives of others as well.”
To learn more, visit www.cldinc.org
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.